vs

Side-by-side financial comparison of Avidbank Holdings, Inc. (AVBH) and Outset Medical, Inc. (OM). Click either name above to swap in a different company.

Outset Medical, Inc. is the larger business by last-quarter revenue ($28.9M vs $28.0M, roughly 1.0× Avidbank Holdings, Inc.). Avidbank Holdings, Inc. runs the higher net margin — 32.3% vs -67.5%, a 99.8% gap on every dollar of revenue.

Avidbank Holdings, Inc. is a U.S.-based financial holding company operating through its subsidiary AvidBank. It offers commercial banking products and services primarily to small and medium-sized enterprises, business owners, and high-net-worth individuals across California, including commercial loans, deposit accounts, cash management, and customized financing solutions for sectors like manufacturing, technology, real estate and professional services.

Outset Medical, Inc. is a medical technology company focused on developing and commercializing innovative dialysis solutions for patients living with kidney disease. Its flagship Tablo Hemodialysis System supports use in acute care facilities, outpatient clinics, and home settings, serving healthcare providers and patients across the U.S. and select international markets.

AVBH vs OM — Head-to-Head

Bigger by revenue
OM
OM
1.0× larger
OM
$28.9M
$28.0M
AVBH
Higher net margin
AVBH
AVBH
99.8% more per $
AVBH
32.3%
-67.5%
OM

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
AVBH
AVBH
OM
OM
Revenue
$28.0M
$28.9M
Net Profit
$9.0M
$-19.5M
Gross Margin
42.4%
Operating Margin
-61.1%
Net Margin
32.3%
-67.5%
Revenue YoY
-2.0%
Net Profit YoY
65.9%
24.0%
EPS (diluted)
$0.84
$0.33

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AVBH
AVBH
OM
OM
Q1 26
$28.0M
Q4 25
$26.8M
$28.9M
Q3 25
$48.0K
$29.4M
Q2 25
$21.8M
$31.4M
Q1 25
$29.8M
Q4 24
$29.5M
Q3 24
$28.7M
Q2 24
$27.4M
Net Profit
AVBH
AVBH
OM
OM
Q1 26
$9.0M
Q4 25
$6.9M
$-19.5M
Q3 25
$-37.7M
$-17.8M
Q2 25
$5.8M
$-18.5M
Q1 25
$-25.8M
Q4 24
$-25.6M
Q3 24
$-27.9M
Q2 24
$-34.5M
Gross Margin
AVBH
AVBH
OM
OM
Q1 26
Q4 25
42.4%
Q3 25
39.4%
Q2 25
37.8%
Q1 25
37.2%
Q4 24
36.5%
Q3 24
34.3%
Q2 24
35.7%
Operating Margin
AVBH
AVBH
OM
OM
Q1 26
Q4 25
-61.1%
Q3 25
-110491.7%
-53.7%
Q2 25
38.0%
-53.7%
Q1 25
-55.1%
Q4 24
-74.2%
Q3 24
-83.2%
Q2 24
-112.3%
Net Margin
AVBH
AVBH
OM
OM
Q1 26
32.3%
Q4 25
25.9%
-67.5%
Q3 25
-78614.6%
-60.6%
Q2 25
26.6%
-59.0%
Q1 25
-86.7%
Q4 24
-87.0%
Q3 24
-97.5%
Q2 24
-125.8%
EPS (diluted)
AVBH
AVBH
OM
OM
Q1 26
$0.84
Q4 25
$0.65
$0.33
Q3 25
$-4.12
$-1.00
Q2 25
$0.75
$-1.04
Q1 25
$-3.66
Q4 24
$-7.21
Q3 24
$-8.02
Q2 24
$-9.96

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AVBH
AVBH
OM
OM
Cash + ST InvestmentsLiquidity on hand
$168.9M
Total DebtLower is stronger
$55.0M
$96.2M
Stockholders' EquityBook value
$287.2M
$127.0M
Total Assets
$2.5B
$264.5M
Debt / EquityLower = less leverage
0.19×
0.76×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AVBH
AVBH
OM
OM
Q1 26
Q4 25
$168.9M
Q3 25
$178.6M
Q2 25
$184.1M
Q1 25
$189.0M
Q4 24
$158.7M
Q3 24
$175.6M
Q2 24
$194.8M
Total Debt
AVBH
AVBH
OM
OM
Q1 26
$55.0M
Q4 25
$60.0M
$96.2M
Q3 25
Q2 25
Q1 25
Q4 24
$197.4M
Q3 24
Q2 24
Stockholders' Equity
AVBH
AVBH
OM
OM
Q1 26
$287.2M
Q4 25
$278.4M
$127.0M
Q3 25
$273.1M
$142.4M
Q2 25
$204.4M
$154.8M
Q1 25
$169.9M
Q4 24
$26.8M
Q3 24
$47.8M
Q2 24
$68.6M
Total Assets
AVBH
AVBH
OM
OM
Q1 26
$2.5B
Q4 25
$2.5B
$264.5M
Q3 25
$2.4B
$277.3M
Q2 25
$2.4B
$288.8M
Q1 25
$301.2M
Q4 24
$275.8M
Q3 24
$292.9M
Q2 24
$314.5M
Debt / Equity
AVBH
AVBH
OM
OM
Q1 26
0.19×
Q4 25
0.22×
0.76×
Q3 25
Q2 25
Q1 25
Q4 24
7.36×
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AVBH
AVBH
OM
OM
Operating Cash FlowLast quarter
$-9.5M
Free Cash FlowOCF − Capex
$-9.7M
FCF MarginFCF / Revenue
-33.7%
Capex IntensityCapex / Revenue
0.8%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-47.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AVBH
AVBH
OM
OM
Q1 26
Q4 25
$-9.5M
Q3 25
$12.4M
$-6.3M
Q2 25
$10.7M
$-4.8M
Q1 25
$-25.7M
Q4 24
$-16.5M
Q3 24
$-20.6M
Q2 24
$-33.3M
Free Cash Flow
AVBH
AVBH
OM
OM
Q1 26
Q4 25
$-9.7M
Q3 25
$12.4M
$-6.5M
Q2 25
$10.6M
$-5.1M
Q1 25
$-25.8M
Q4 24
$-16.5M
Q3 24
$-21.0M
Q2 24
$-33.5M
FCF Margin
AVBH
AVBH
OM
OM
Q1 26
Q4 25
-33.7%
Q3 25
25783.3%
-22.0%
Q2 25
48.6%
-16.3%
Q1 25
-86.7%
Q4 24
-56.1%
Q3 24
-73.1%
Q2 24
-122.2%
Capex Intensity
AVBH
AVBH
OM
OM
Q1 26
Q4 25
0.8%
Q3 25
72.9%
0.5%
Q2 25
0.3%
0.9%
Q1 25
0.4%
Q4 24
0.1%
Q3 24
1.4%
Q2 24
0.4%
Cash Conversion
AVBH
AVBH
OM
OM
Q1 26
Q4 25
Q3 25
Q2 25
1.84×
Q1 25
Q4 24
Q3 24
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AVBH
AVBH

Net Interest Income$26.5M95%
Noninterest Income$1.5M5%

OM
OM

Consumables Product$13.5M47%
Service And Other Revenue$9.0M31%
Consoles Product$6.4M22%

Related Comparisons